Comparison of mortality rates after acute myocardial infarction in smokers versus nonsmokers - 26/08/11
, Santosh C. Sutradhar, PhD c, Kenneth Dickstein, PhD, MD a, bOPTIMAAL Study Group
Résumé |
According to several reports, patients who smoke paradoxically have favorable outcomes after acute myocardial infarctions (AMIs) compared with nonsmokers. The Optimal Trial in Myocardial Infarction With the Angiotensin II Antagonist Losartan evaluated 5,477 high-risk patients after AMIs. Patients with a history of smoking had a 17% smaller risk for death (hazard ratio 0.83, p = 0.005) compared with nonsmokers. After adjustment for age only, without correction for other co-morbidities or risk factors, the lower all-cause mortality in smoker population was explained by the smokers' generally younger age, with better prognoses due to their age.
Le texte complet de cet article est disponible en PDF.
Vol 94 - N° 5
P. 632-636 - septembre 2004 Retour au numéro
Article précédent
- Comparison of three-year outcomes after coronary stenting versus coronary artery bypass grafting in patients with multivessel coronary disease, including involvement of the left anterior descending coronary artery proximally (a subanalysis of the arterial revascularization therapies study trial)
- Jiro Aoki, Andrew T.L. Ong, Chourmouzios A. Arampatzis, Maniyal Vijaykumar, Gaston A. Rodriguez Granillo, Clemens M.C. Disco, Patrick W. Serruys
- Magnitude and impact of treatment delays on weeknights and weekends in patients undergoing primary angioplasty for acute myocardial infarction (the cadillac trial)
- H. Mehrdad Sadeghi, Cindy L. Grines, Harish R. Chandra, Roxana Mehran, Martin Fahy, David A. Cox, Eulogio Garcia, James E. Tcheng, John J. Griffin, Thomas D. Stuckey, Alexandra J. Lansky, William W. O'Neill, Gregg W. Stone
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?